Global Psychedelic Drugs Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Psychedelic Drugs Market Size 2017-2028

2.1.2 Psychedelic Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Psychedelic Drugs Segment by Type

2.2.1 Psilocybin

2.2.2 LSD

2.2.3 MDMA

2.2.4 DMT

2.2.5 Ketamine

2.2.6 Others

2.3 Psychedelic Drugs Market Size by Type

2.3.1 Psychedelic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Psychedelic Drugs Market Size Market Share by Type (2017-2022)

2.4 Psychedelic Drugs Segment by Application

2.4.1 Depressive Disorders

2.4.2 Post-Traumatic Stress Disorders

2.4.3 Substance Abuse Disorders

2.4.4 Obsessive Compulsive Disorders

2.4.5 Others

2.5 Psychedelic Drugs Market Size by Application

2.5.1 Psychedelic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Psychedelic Drugs Market Size Market Share by Application (2017-2022)

3 Psychedelic Drugs Market Size by Player

3.1 Psychedelic Drugs Market Size Market Share by Players

3.1.1 Global Psychedelic Drugs Revenue by Players (2020-2022)

3.1.2 Global Psychedelic Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Psychedelic Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Psychedelic Drugs by Regions

4.1 Psychedelic Drugs Market Size by Regions (2017-2022)

4.2 Americas Psychedelic Drugs Market Size Growth (2017-2022)

4.3 APAC Psychedelic Drugs Market Size Growth (2017-2022)

4.4 Europe Psychedelic Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Psychedelic Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Psychedelic Drugs Market Size by Country (2017-2022)

5.2 Americas Psychedelic Drugs Market Size by Type (2017-2022)

5.3 Americas Psychedelic Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Psychedelic Drugs Market Size by Region (2017-2022)

6.2 APAC Psychedelic Drugs Market Size by Type (2017-2022)

6.3 APAC Psychedelic Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Psychedelic Drugs by Country (2017-2022)

7.2 Europe Psychedelic Drugs Market Size by Type (2017-2022)

7.3 Europe Psychedelic Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Psychedelic Drugs by Region (2017-2022)

8.2 Middle East & Africa Psychedelic Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Psychedelic Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Psychedelic Drugs Market Forecast

10.1 Global Psychedelic Drugs Forecast by Regions (2023-2028)

10.1.1 Global Psychedelic Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Psychedelic Drugs Forecast

10.1.3 APAC Psychedelic Drugs Forecast

10.1.4 Europe Psychedelic Drugs Forecast

10.1.5 Middle East & Africa Psychedelic Drugs Forecast

10.2 Americas Psychedelic Drugs Forecast by Country (2023-2028)

10.2.1 United States Psychedelic Drugs Market Forecast

10.2.2 Canada Psychedelic Drugs Market Forecast

10.2.3 Mexico Psychedelic Drugs Market Forecast

10.2.4 Brazil Psychedelic Drugs Market Forecast

10.3 APAC Psychedelic Drugs Forecast by Region (2023-2028)

10.3.1 China Psychedelic Drugs Market Forecast

10.3.2 Japan Psychedelic Drugs Market Forecast

10.3.3 Korea Psychedelic Drugs Market Forecast

10.3.4 Southeast Asia Psychedelic Drugs Market Forecast

10.3.5 India Psychedelic Drugs Market Forecast

10.3.6 Australia Psychedelic Drugs Market Forecast

10.4 Europe Psychedelic Drugs Forecast by Country (2023-2028)

10.4.1 Germany Psychedelic Drugs Market Forecast

10.4.2 France Psychedelic Drugs Market Forecast

10.4.3 UK Psychedelic Drugs Market Forecast

10.4.4 Italy Psychedelic Drugs Market Forecast

10.4.5 Russia Psychedelic Drugs Market Forecast

10.5 Middle East & Africa Psychedelic Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Psychedelic Drugs Market Forecast

10.5.2 South Africa Psychedelic Drugs Market Forecast

10.5.3 Israel Psychedelic Drugs Market Forecast

10.5.4 Turkey Psychedelic Drugs Market Forecast

10.5.5 GCC Countries Psychedelic Drugs Market Forecast

10.6 Global Psychedelic Drugs Forecast by Type (2023-2028)

10.7 Global Psychedelic Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 COMPASS Pathways PLC

11.1.1 COMPASS Pathways PLC Company Information

11.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Offered

11.1.3 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 COMPASS Pathways PLC Main Business Overview

11.1.5 COMPASS Pathways PLC Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Psychedelic Drugs Product Offered

11.2.3 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Eli Lilly

11.3.1 Eli Lilly Company Information

11.3.2 Eli Lilly Psychedelic Drugs Product Offered

11.3.3 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Eli Lilly Main Business Overview

11.3.5 Eli Lilly Latest Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Information

11.4.2 GlaxoSmithKline Psychedelic Drugs Product Offered

11.4.3 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 GlaxoSmithKline Main Business Overview

11.4.5 GlaxoSmithKline Latest Developments

11.5 Cybin Inc

11.5.1 Cybin Inc Company Information

11.5.2 Cybin Inc Psychedelic Drugs Product Offered

11.5.3 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Cybin Inc Main Business Overview

11.5.5 Cybin Inc Latest Developments

11.6 Field Trip Health

11.6.1 Field Trip Health Company Information

11.6.2 Field Trip Health Psychedelic Drugs Product Offered

11.6.3 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Field Trip Health Main Business Overview

11.6.5 Field Trip Health Latest Developments

11.7 ATAI Life Sciences

11.7.1 ATAI Life Sciences Company Information

11.7.2 ATAI Life Sciences Psychedelic Drugs Product Offered

11.7.3 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 ATAI Life Sciences Main Business Overview

11.7.5 ATAI Life Sciences Latest Developments

11.8 NUMINUS WELLNESS

11.8.1 NUMINUS WELLNESS Company Information

11.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Offered

11.8.3 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 NUMINUS WELLNESS Main Business Overview

11.8.5 NUMINUS WELLNESS Latest Developments

11.9 MindMed

11.9.1 MindMed Company Information

11.9.2 MindMed Psychedelic Drugs Product Offered

11.9.3 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 MindMed Main Business Overview

11.9.5 MindMed Latest Developments

11.10 HAVN Life Sciences

11.10.1 HAVN Life Sciences Company Information

11.10.2 HAVN Life Sciences Psychedelic Drugs Product Offered

11.10.3 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 HAVN Life Sciences Main Business Overview

11.10.5 HAVN Life Sciences Latest Developments

11.11 Seelos Therapeutics

11.11.1 Seelos Therapeutics Company Information

11.11.2 Seelos Therapeutics Psychedelic Drugs Product Offered

11.11.3 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Seelos Therapeutics Main Business Overview

11.11.5 Seelos Therapeutics Latest Developments

11.12 Jannsen

11.12.1 Jannsen Company Information

11.12.2 Jannsen Psychedelic Drugs Product Offered

11.12.3 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Jannsen Main Business Overview

11.12.5 Jannsen Latest Developments

11.13 Acadia Pharmaceuticals

11.13.1 Acadia Pharmaceuticals Company Information

11.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Offered

11.13.3 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Acadia Pharmaceuticals Main Business Overview

11.13.5 Acadia Pharmaceuticals Latest Developments

11.14 Intellipharmaceutics

11.14.1 Intellipharmaceutics Company Information

11.14.2 Intellipharmaceutics Psychedelic Drugs Product Offered

11.14.3 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Intellipharmaceutics Main Business Overview

11.14.5 Intellipharmaceutics Latest Developments

11.15 Revive Therapeutics

11.15.1 Revive Therapeutics Company Information

11.15.2 Revive Therapeutics Psychedelic Drugs Product Offered

11.15.3 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Revive Therapeutics Main Business Overview

11.15.5 Revive Therapeutics Latest Developments

11.16 Mydecine Innovations Group

11.16.1 Mydecine Innovations Group Company Information

11.16.2 Mydecine Innovations Group Psychedelic Drugs Product Offered

11.16.3 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Mydecine Innovations Group Main Business Overview

11.16.5 Mydecine Innovations Group Latest Developments

11.17 Red Light Holland

11.17.1 Red Light Holland Company Information

11.17.2 Red Light Holland Psychedelic Drugs Product Offered

11.17.3 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Red Light Holland Main Business Overview

11.17.5 Red Light Holland Latest Developments

11.18 Braxia Scientific

11.18.1 Braxia Scientific Company Information

11.18.2 Braxia Scientific Psychedelic Drugs Product Offered

11.18.3 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Braxia Scientific Main Business Overview

11.18.5 Braxia Scientific Latest Developments

11.19 Mind Cure Health

11.19.1 Mind Cure Health Company Information

11.19.2 Mind Cure Health Psychedelic Drugs Product Offered

11.19.3 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Mind Cure Health Main Business Overview

11.19.5 Mind Cure Health Latest Developments

11.20 Entheon Biomedical

11.20.1 Entheon Biomedical Company Information

11.20.2 Entheon Biomedical Psychedelic Drugs Product Offered

11.20.3 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Entheon Biomedical Main Business Overview

11.20.5 Entheon Biomedical Latest Developments

12 Research Findings and Conclusion

Table 1. Psychedelic Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Psilocybin

Table 3. Major Players of LSD

Table 4. Major Players of MDMA

Table 5. Major Players of DMT

Table 6. Major Players of Ketamine

Table 7. Major Players of Others

Table 8. Psychedelic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Psychedelic Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Psychedelic Drugs Market Size Market Share by Type (2017-2022)

Table 11. Psychedelic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Psychedelic Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Psychedelic Drugs Market Size Market Share by Application (2017-2022)

Table 14. Global Psychedelic Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Psychedelic Drugs Revenue Market Share by Player (2020-2022)

Table 16. Psychedelic Drugs Key Players Head office and Products Offered

Table 17. Psychedelic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Psychedelic Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Psychedelic Drugs Market Size Market Share by Regions (2017-2022)

Table 22. Americas Psychedelic Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Psychedelic Drugs Market Size Market Share by Country (2017-2022)

Table 24. Americas Psychedelic Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Psychedelic Drugs Market Size Market Share by Type (2017-2022)

Table 26. Americas Psychedelic Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Psychedelic Drugs Market Size Market Share by Application (2017-2022)

Table 28. APAC Psychedelic Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Psychedelic Drugs Market Size Market Share by Region (2017-2022)

Table 30. APAC Psychedelic Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Psychedelic Drugs Market Size Market Share by Type (2017-2022)

Table 32. APAC Psychedelic Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Psychedelic Drugs Market Size Market Share by Application (2017-2022)

Table 34. Europe Psychedelic Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Psychedelic Drugs Market Size Market Share by Country (2017-2022)

Table 36. Europe Psychedelic Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Psychedelic Drugs Market Size Market Share by Type (2017-2022)

Table 38. Europe Psychedelic Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Psychedelic Drugs Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Psychedelic Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Psychedelic Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Psychedelic Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Psychedelic Drugs

Table 47. Key Market Challenges & Risks of Psychedelic Drugs

Table 48. Key Industry Trends of Psychedelic Drugs

Table 49. Global Psychedelic Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Psychedelic Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Psychedelic Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Psychedelic Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Psychedelic Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Psychedelic Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 56. COMPASS Pathways PLC Psychedelic Drugs Product Offered

Table 57. COMPASS Pathways PLC Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. COMPASS Pathways PLC Main Business

Table 59. COMPASS Pathways PLC Latest Developments

Table 60. Pfizer Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 61. Pfizer Psychedelic Drugs Product Offered

Table 62. Pfizer Main Business

Table 63. Pfizer Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Pfizer Latest Developments

Table 65. Eli Lilly Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 66. Eli Lilly Psychedelic Drugs Product Offered

Table 67. Eli Lilly Main Business

Table 68. Eli Lilly Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Eli Lilly Latest Developments

Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 71. GlaxoSmithKline Psychedelic Drugs Product Offered

Table 72. GlaxoSmithKline Main Business

Table 73. GlaxoSmithKline Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. GlaxoSmithKline Latest Developments

Table 75. Cybin Inc Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 76. Cybin Inc Psychedelic Drugs Product Offered

Table 77. Cybin Inc Main Business

Table 78. Cybin Inc Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Cybin Inc Latest Developments

Table 80. Field Trip Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 81. Field Trip Health Psychedelic Drugs Product Offered

Table 82. Field Trip Health Main Business

Table 83. Field Trip Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Field Trip Health Latest Developments

Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 86. ATAI Life Sciences Psychedelic Drugs Product Offered

Table 87. ATAI Life Sciences Main Business

Table 88. ATAI Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. ATAI Life Sciences Latest Developments

Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 91. NUMINUS WELLNESS Psychedelic Drugs Product Offered

Table 92. NUMINUS WELLNESS Main Business

Table 93. NUMINUS WELLNESS Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. NUMINUS WELLNESS Latest Developments

Table 95. MindMed Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 96. MindMed Psychedelic Drugs Product Offered

Table 97. MindMed Main Business

Table 98. MindMed Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. MindMed Latest Developments

Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 101. HAVN Life Sciences Psychedelic Drugs Product Offered

Table 102. HAVN Life Sciences Main Business

Table 103. HAVN Life Sciences Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. HAVN Life Sciences Latest Developments

Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 106. Seelos Therapeutics Psychedelic Drugs Product Offered

Table 107. Seelos Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Seelos Therapeutics Main Business

Table 109. Seelos Therapeutics Latest Developments

Table 110. Jannsen Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 111. Jannsen Psychedelic Drugs Product Offered

Table 112. Jannsen Main Business

Table 113. Jannsen Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Jannsen Latest Developments

Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 116. Acadia Pharmaceuticals Psychedelic Drugs Product Offered

Table 117. Acadia Pharmaceuticals Main Business

Table 118. Acadia Pharmaceuticals Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Acadia Pharmaceuticals Latest Developments

Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 121. Intellipharmaceutics Psychedelic Drugs Product Offered

Table 122. Intellipharmaceutics Main Business

Table 123. Intellipharmaceutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Intellipharmaceutics Latest Developments

Table 125. Revive Therapeutics Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 126. Revive Therapeutics Psychedelic Drugs Product Offered

Table 127. Revive Therapeutics Main Business

Table 128. Revive Therapeutics Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 129. Revive Therapeutics Latest Developments

Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 131. Mydecine Innovations Group Psychedelic Drugs Product Offered

Table 132. Mydecine Innovations Group Main Business

Table 133. Mydecine Innovations Group Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 134. Mydecine Innovations Group Latest Developments

Table 135. Red Light Holland Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 136. Red Light Holland Psychedelic Drugs Product Offered

Table 137. Red Light Holland Main Business

Table 138. Red Light Holland Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 139. Red Light Holland Latest Developments

Table 140. Braxia Scientific Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 141. Braxia Scientific Psychedelic Drugs Product Offered

Table 142. Braxia Scientific Main Business

Table 143. Braxia Scientific Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 144. Braxia Scientific Latest Developments

Table 145. Mind Cure Health Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 146. Mind Cure Health Psychedelic Drugs Product Offered

Table 147. Mind Cure Health Main Business

Table 148. Mind Cure Health Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 149. Mind Cure Health Latest Developments

Table 150. Entheon Biomedical Details, Company Type, Psychedelic Drugs Area Served and Its Competitors

Table 151. Entheon Biomedical Psychedelic Drugs Product Offered

Table 152. Entheon Biomedical Main Business

Table 153. Entheon Biomedical Psychedelic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 154. Entheon Biomedical Latest Developments

List of Figures

Figure 1. Psychedelic Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Psychedelic Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Psychedelic Drugs Market Size Market Share by Type in 2021

Figure 7. Psychedelic Drugs in Depressive Disorders

Figure 8. Global Psychedelic Drugs Market: Depressive Disorders (2017-2022) & ($ Millions)

Figure 9. Psychedelic Drugs in Post-Traumatic Stress Disorders

Figure 10. Global Psychedelic Drugs Market: Post-Traumatic Stress Disorders (2017-2022) & ($ Millions)

Figure 11. Psychedelic Drugs in Substance Abuse Disorders

Figure 12. Global Psychedelic Drugs Market: Substance Abuse Disorders (2017-2022) & ($ Millions)

Figure 13. Psychedelic Drugs in Obsessive Compulsive Disorders

Figure 14. Global Psychedelic Drugs Market: Obsessive Compulsive Disorders (2017-2022) & ($ Millions)

Figure 15. Psychedelic Drugs in Others

Figure 16. Global Psychedelic Drugs Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Psychedelic Drugs Market Size Market Share by Application in 2021

Figure 18. Global Psychedelic Drugs Revenue Market Share by Player in 2021

Figure 19. Global Psychedelic Drugs Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Psychedelic Drugs Market Size 2017-2022 ($ Millions)

Figure 21. APAC Psychedelic Drugs Market Size 2017-2022 ($ Millions)

Figure 22. Europe Psychedelic Drugs Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Psychedelic Drugs Market Size 2017-2022 ($ Millions)

Figure 24. Americas Psychedelic Drugs Value Market Share by Country in 2021

Figure 25. Americas Psychedelic Drugs Consumption Market Share by Type in 2021

Figure 26. Americas Psychedelic Drugs Market Size Market Share by Application in 2021

Figure 27. United States Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Psychedelic Drugs Market Size Market Share by Region in 2021

Figure 32. APAC Psychedelic Drugs Market Size Market Share by Application in 2021

Figure 33. China Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Psychedelic Drugs Market Size Market Share by Country in 2021

Figure 40. Europe Psychedelic Drugs Market Size Market Share by Type in 2021

Figure 41. Europe Psychedelic Drugs Market Size Market Share by Application in 2021

Figure 42. Germany Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Psychedelic Drugs Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Psychedelic Drugs Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Psychedelic Drugs Market Size Market Share by Application in 2021

Figure 50. Egypt Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Psychedelic Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 56. APAC Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 57. Europe Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 59. United States Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Canada Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 63. China Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Japan Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Korea Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 67. India Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Australia Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Germany Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 70. France Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 71. UK Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Italy Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Russia Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 74. Spain Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 77. Israel Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Psychedelic Drugs Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Psychedelic Drugs Market Size 2023-2028 ($ Millions)